Ensign Peak Advisors’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-19,976
Closed -$147K 1722
2024
Q3
$147K Hold
19,976
﹤0.01% 1697
2024
Q2
$211K Buy
19,976
+1,650
+9% +$20.9K ﹤0.01% 1694
2024
Q1
$253K Sell
18,326
-924
-5% -$14.4K ﹤0.01% 1698
2023
Q4
$374K Hold
19,250
﹤0.01% 1693
2023
Q3
$408K Hold
19,250
﹤0.01% 1643
2023
Q2
$639K Hold
19,250
﹤0.01% 1544
2023
Q1
$757K Buy
19,250
+2,000
+12% +$83.1K ﹤0.01% 1459
2022
Q4
$727K Buy
17,250
+600
+4% +$23.1K ﹤0.01% 1422
2022
Q3
$556K Sell
16,650
-3,370
-17% -$140K ﹤0.01% 1398
2022
Q2
$867K Hold
20,020
﹤0.01% 1187
2022
Q1
$959K Hold
20,020
﹤0.01% 1231
2021
Q4
$1.02M Sell
20,020
-28,100
-58% -$1.25M ﹤0.01% 1272
2021
Q3
$1.95M Hold
48,120
﹤0.01% 1144
2021
Q2
$2.73M Sell
48,120
-41,490
-46% -$2.36M 0.01% 941
2021
Q1
$4.74M Buy
89,610
+27,441
+44% +$1.49M 0.01% 642
2020
Q4
$3.4M Sell
62,169
-664,261
-91% -$35M 0.01% 772
2020
Q3
$36.4M Buy
726,430
+17,050
+2% +$808K 0.09% 183
2020
Q2
$27.1M Buy
709,380
+252,803
+55% +$8.12M 0.07% 231
2020
Q1
$9.98M Buy
456,577
+17,817
+4% +$536K 0.03% 349
2019
Q4
$18M Buy
+438,760
New +$17.9M 0.05% 305

Other funds holding NUS

Ensign Peak Advisors's NUS Position: Q4 2024 in Review

Ensign Peak Advisors sold out of Nu Skin (NUS) in Q4 2024, closing a stake of 19,976 shares — an estimated $147K sold.

Ensign Peak Advisors first reported a position in NUS in Q4 2019 and held it in 20 quarters. The position peaked at $36.4M in Q3 2020. 200 funds tracked by Wall St. Rank hold NUS as of Q4 2024.

  • Ensign Peak Advisors reported no remaining Nu Skin position as of Q4 2024 after selling out during the quarter.
  • Ensign Peak Advisors sold 19,976 Nu Skin shares in Q4 2024, an estimated $147K.
  • Ensign Peak Advisors first reported a position in Nu Skin in Q4 2019 and held it in 20 quarters.
  • Ensign Peak Advisors's Nu Skin position peaked at $36.4M in Q3 2020.
  • 200 funds tracked by Wall St. Rank held Nu Skin as of Q4 2024.

Based on Ensign Peak Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.